Published 21 September 2020
In this issue
Human Medicines
- COVID-19: Queries and Updates
- COVID-19 Update
- Getting Brexit Ready
- Nitrosamine Impurities: Conclusion of Nitrosamines 5.3 Review and Requirements for Chemical and Biological Products
- Interchangeable Medicinal Products
- IE Requirements Regarding Release of Batches of Vaccines or Blood-derived Medicinal Products
- Multilingual Packaging Update
Veterinary Medicines
- Brexit Implications for Veterinary Medicinal Products on the Market in Ireland
- Changes to Submission Requirements of Joint-labelled Mock-ups Post Renewal Procedures
- Ongoing Operations during the COVID-19 Pandemic
- HPRA Input into Revision of National Legislation on Veterinary Medicinal Products
Compliance
- Controlled Drugs: Notice Regarding PharmaTrust
- Inclusion of Postcodes (Eircodes) on MIAs and GMP Certificates
- European Commission Call for Data on Prostaglandins and their Analogues used in Cosmetic Products
- Brexit Transitional Period: Implications for Cosmetic Product Companies up to 31 December 2020
- Addition of Imported Medicinal Products to Annex 8 of a Manufacturer’s / Importer’s Authorisation (MIA)
- Distant Assessments (Remote Inspections)